Medical experts engaged in a discussion about advancing pediatric acute myeloid leukemia (AML) treatment strategies. Venetoclax, a promising drug, was a focal point, and its potential inclusion in pediatric protocols was explored. The challenge of adapting adult regimens to pediatric patients while considering drug forms suitable for children was discussed.
REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
The importance of collaborative trials, merging efforts across pediatric and adult AML, emerged as a key theme, aiming to address limited patient numbers and accelerate progress.
Advertisement Single Between Content
Advertisement Single Between Content
Advertisement Single Between Content
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content